Cravath Swaine & Moore from representing Air Products, alleging that there was a conflict of interest becauseIn Airgas v. Cravath Swaine & Moore, Airgas is seeking to stop
Law firm news by topic » Cravath
Cravath, Swaine & Moore rejected claims that the firm breached its fiduciary duty to Airgas byIn Pennsylvania state court proceedings on Tuesday, lawyers representing
Cravath, Swaine & Moore last Friday over the firm's role as legal adviser to rival Air Products and Chemicals on its $5.1Industrial gas producer Airgas filed suit against
Cravath, Swaine & Moore has informed law students who summered at the firm last year that some of them can start this fall, one year earlier than planned under a previously
Cravath, Swaine and Moore, presiding partner at Cravath, Swaine & Moore from 1999 to 2006, died Thursday from cancer at 66. Joffe graduated fromRobert Joffe of
Seven major US law firm signed to a letter to the Securities and Exchange Commission (SEC) expressing their opinion on how to best implement a proposal to allow shareholders to nominate company directors. The unusual
Wall Street law firm Cravath Swaine Moore is asking their incoming first-years to delay start dates for a few months, follwong other firms like Latham & Watkins, White & Case.
Linklaters was hired to advise on four of the 10 biggest mergers and acquisitions in 2008, leading the M&A league table published by Bloomberg today. In the smallest deal market in four years, total announced mergers and
Cravath, Swaine & Moore announced reduced end-of-year associate bonuses last week in a memo to its staff. The numbers are down sharply from last year. The bonuses start at a pro-rated $17,500 for first-year associates
Cravath, Swaine & Moore has withdrawn as pro bono counsel for a convict who won a new trial on the basis of another man’s audiotaped murder confession that is now alleged to be a fake...
Wachtell Lipton Rosen & Katz and Sullivan & Cromwell have snared the lead roles on Morgan Stanley’s $9bn (£5.2bn) injection from Japanese bank Mitsubishi UFJ Financial Group...
Cravath Swaine & Moore and Davis Polk & Wardwell have won places advising JP Morgan Chase and Citibank on the creation of the $70bn (£39.6bn) liquidity facility set up by leading investment banks in the aftermath of
Cravath, Swaine & Moore is advising Bristol-Myers Squibb on the planned acquisition of the rest of ImClone Systems, the maker of the best-selling cancer drug Erbitux, for $4.5 billion. Corporate partner Allen